The potential role of biomarkers in HIV preventive vaccine trials.


BACKGROUND Successful conduct of HIV vaccine efficacy trials entails identification and enrollment of at-risk populations, assessment of appropriate end points as measures of vaccine efficacy for prevention of HIV acquisition, and amelioration of disease course among infected vaccinees, as well as identification of potential confounders or effect modifiers… (More)
DOI: 10.1097/QAI.0b013e3181adcbbe


  • Presentations referencing similar topics